A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Journal
Therapeutic Advances in Medical Oncology
Journal Volume
11
Date Issued
2019
Author(s)
Qin S.
Chan S.L.
Sukeepaisarnjaroen W.
Han G.
Choo S.P.
Sriuranpong V.
Pan H.
Yau T.
Guo Y.
Chen M.
Ren Z.
Xu J.
Yen C.-J.
Manenti L.
Gu Y.
Sun Y.
Tiedt R.
Hao L.
Song W.
Tanwandee T.
SDGs
Publisher
SAGE Publications Inc.
Type
journal article